Cryopreservation of cord blood after liquid storage.

BACKGROUND The processing of cord blood may result in delays prior to RBC depletion and cryopreservation. The overall objective of this investigation is to determine the influence of liquid storage prior to cryopreservation on the post-thaw viability. METHODS UC blood supplemented with CPD anticoagulant (CB) was obtained from normal donors with informed consent. CB was stored undiluted, or diluted with 1:1 ratio of storage solution STM-sav for up to 72 h. The undiluted control samples were stored at room temperature. CB samples supplemented with STM-sav were stored at 4 degrees C. After completion of the storage protocol, the sample was RBC depleted, frozen, stored, thawed, and assayed for viability. Nucleated cell counts, percentage of CD34+ cells, and frequency of colony formation were determined during liquid storage and after cryopreservation. RESULTS The post-thaw mononuclear cell recovery and viability of cord blood stored for 72 h was significantly lower than that of cord blood stored for 24 h prior to cryopreservation. This difference was true for cord bloods stored in STM-sav and controls. Dilution of the cord blood with STM-sav improved the frequency of CFU-GM observed. DISCUSSION Liquid storage of cord blood for 24 h prior to cryopreservation does not adversely influence the post-thaw cell recovery. The use of a storage solution (STM-Sav) enhances the retention of colony-forming capabilities post-thaw. These and other studies provide an important foundation for the development of integrated protocols for cord blood banking.

[1]  R. Warwick,et al.  Cord blood banking. , 2004, Best practice & research. Clinical obstetrics & gynaecology.

[2]  A. Hubel,et al.  Short‐term liquid storage of umbilical cord blood , 2003, Transfusion.

[3]  P. Rebulla.  Cord blood banking 2002: 112,010 of 7,914,773 chances , 2002, Transfusion.

[4]  A. Hubel,et al.  Noncryopreserved Bone Marrow Storage in STM-Sav, an Infusible-Grade Cell Storage Solution , 2002 .

[5]  J Wagner,et al.  Current status of cord blood banking and transplantation in the United States and Europe. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  Sutherland,et al.  Human UC-blood banking: impact of blood volume, cell separation and cryopreservation on leukocyte and CD34(+) cell recovery. , 2001, Cytotherapy.

[7]  P. Huijgens,et al.  Storage of unprocessed G-CSF-mobilized whole blood in a modified Leibovitz's L15 medium preserves clonogenic capacity for at least 7 days , 2001, Bone Marrow Transplantation.

[8]  J. Hows,et al.  Status of umbilical cord blood transplantation in the year 2001 , 2001, Journal of clinical pathology.

[9]  S. Stanworth,et al.  An international survey of unrelated umbilical cord blood banking , 2001, Vox sanguinis.

[10]  J. McCullough,et al.  HPC viability measurement: trypan blue versus acridine orange and propidium iodide , 2000, Transfusion.

[11]  D. Kadidlo,et al.  Improved progenitor assay standardization using peripheral blood progenitor cells from a donor treated with granulocyte–colony‐stimulating factor , 1999, Transfusion.

[12]  A. Hubel,et al.  Development of an infusible-grade solution for non-cryopreserved hematopoietic cell storage. , 1999, Cytotherapy.

[13]  M. Gordon,et al.  Optimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantation , 1999, Bone Marrow Transplantation.

[14]  J. Dick,et al.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Le Forestier,et al.  Characteristics of peripheral blood progenitor cells frozen after 24 hours of liquid storage. , 1996, Journal of hematotherapy.

[16]  R. Marcus,et al.  High-dose melphalan followed by autograft employing non-cryopreserved peripheral blood progenitor cells in children. , 1996, European journal of cancer.

[17]  D. Sutherland,et al.  The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. , 1996, Journal of hematotherapy.

[18]  R. Marcus,et al.  The use of non-cryopreserved peripheral blood progenitor cells in autologous transplantation. , 1995, Bone marrow transplantation.

[19]  G. Ruiz-Argüelles,et al.  Filgrastim‐mobilized peripheral‐blood stem cells can be stored at 4 degrees and used in autografts to rescue high‐dose chemotherapy , 1995, American journal of hematology.

[20]  R. Marcus,et al.  Liquid storage of peripheral blood progenitor cells for transplantation. , 1994, Bone marrow transplantation.

[21]  L. Seymour,et al.  Non‐cryopreserved, limited number (1 or 2) peripheral blood progenitor cell (PBPC) collections following GCSF administration provide adequate hematologic support for high dose chemotherapy , 1994, Hematological oncology.

[22]  D. Ciavarella.  Hematopoietic stem cell processing and storage. , 1991, Biotechnology.

[23]  E. Zanjani,et al.  Liquid storage of unseparated human bone marrow. Evaluation of hematopoietic progenitors by clonal assay , 1986, Transfusion.

[24]  J. Ungerleider,et al.  Non-frozen preservation of committed hematopoietic stem cells from normal human bone marrow. , 1981, Stem cells.

[25]  W. Robinson,et al.  Liquid storage of bone marrow. , 1979, Experimental hematology.

[26]  H. Kay.  Annotation: BONE MARROW TRANSPLANTATION , 1976 .

[27]  M. Cline,et al.  PRESERVATION OF GRANULOPOIETIC PRECURSORS IN NONFROZEN, STORED HUMAN BONE MARROW , 1976, Transplantation.